- Report
- October 2025
- 190 Pages
Global
From €3147EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,036GBP
- Report
- March 2025
- 200 Pages
India
From €2210EUR$2,490USD£1,919GBP
- Report
- September 2025
- 70 Pages
India
From €3107EUR$3,500USD£2,698GBP
- Report
- September 2025
- 88 Pages
India
From €3107EUR$3,500USD£2,698GBP
- Report
- October 2024
- 270 Pages
China
From €3550EUR$4,000USD£3,083GBP
- Report
- July 2025
- 88 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- October 2024
- 135 Pages
China
From €1598EUR$1,800USD£1,388GBP
Cefixime is an antibiotic used to treat a variety of bacterial infections. It belongs to the third-generation cephalosporin class of antibiotics, which are used to treat infections caused by Gram-negative bacteria. Cefixime is used to treat a wide range of infections, including ear infections, urinary tract infections, and respiratory tract infections. It is also used to treat gonorrhea, a sexually transmitted infection. Cefixime is available in both oral and injectable forms.
Cefixime is a widely used antibiotic in the treatment of bacterial infections. It is generally well tolerated and has a low risk of side effects. It is also cost-effective, making it a popular choice for treating bacterial infections.
Some companies in the Cefixime market include GlaxoSmithKline, Pfizer, Merck, and Sanofi. Show Less Read more